Amylx Pharmaceuticals Inc vs Enovix Corporation — how do they compare? Amylx Pharmaceuticals Inc trades at $23.96 (market cap $2.64B), while Enovix Corporation trades at $4.88 (market cap $1.06B). The key difference: Amylx Pharmaceuticals Inc is far larger — about 2.5× Enovix Corporation's market cap, and Amylx Pharmaceuticals Inc is trading nearer its 52-week high, Enovix Corporation nearer its low. Which is the better fit depends on your goals.
| AMLX | ENVX | |
|---|---|---|
Market Cap | $2.64B | $1.06B |
Sector | Health | Technology |
52-Week High | $24.19 | $13.19 |
52-Week Low | $7.82 | $3.68 |
Enterprise Value | $2.39B | $1.07B |
Trailing returns across standard periods
Latest headlines on both assets
Amylyx Pharmaceuticals is a biopharmaceutical firm focused on developing therapies for rare diseases. Its pipeline includes treatments for conditions like post-bariatric hypoglycemia and congenital hyperinsulinism.
Read more on AMLX →Enovix designs and manufactures advanced silicon-anode lithium-ion batteries. Its technology aims to provide high energy density and improved performance for mobile devices and consumer electronics.
Read more on ENVX →